First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
Citation
Khot, A, Brajanovski, N, Cameron, D et al 2019, 'First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study', Cancer Discovery, vol. 9, no. 8, pp. 1036-1049.Year
2019ANU Authors
Fields of Research
- Haematology
- Cancer Cell Biology
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
